Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SmokeyT: Gamma Tocopherol for Wood Smoke Airway Inflammation
NCT03444298Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jun 2018
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Change in Sputum % Polymorphonuclear Neutrophils With Wood Smoke Particulate Exposure. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03444298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03444298.